Systems Imagination partners with 3Scan to provide 3-dimensional pathology imaging with sophisticated analytical services for ultra high definition translational medicine.
AZBio Expo 2016 featured a panel on”Prediction and Prevention – Medicine in the Age of Information (Panel)” moderated by Chris Yoo, Founder, Chairman & CEO, Systems Imagination; Panelists- Ron Korn, MD PhD, Founder, Chairman and Chief Medical Officer, Imaging Endpoints; Scott Jenkins, PhD, Chairman & CEO, RealTime Oncology, Todd Huffman, CEO, 3Scan
Systems Imagination (SII), a knowledge evolution company, has announced a partnership with 3Scan, Inc. of San Francisco, California, a computational pathology company. This partnership combines 3Scan’s 3dimensional reconstructive imaging process while sectioning tissue samples with the integrative genomic and multiscalar data analysis services offering by SII.
This partnership will result in a comprehensive, multiscalar, molecularly characterized, 3D high resolution analysis of tissue samples for the Healthcare and Life Sciences.
“We have been building key partnerships with transformative companies to launch this ultrahigh definition solution for translating discoveries from life sciences research into actionable clinically relevant insights,” commented Chris Yoo, Chief Executive Officer of Systems Imagination. “We are excited to announce our partnership with 3Scan, a company we believe is going to revolutionize how we view and reconstruct histopathology images. Together, we will be able to provide the pharmaceutical industry with a streamlined solution for more powerful analytical approaches to research and understand the molecular basis of diseases and how the development of innovative therapies they are bringing to market can be accelerated.”
The SII UltraHigh Definition Translational Medicine service offering enables pharmaceutical companies to conduct comprehensive multiscalar genomic analyses for clinical drug development with corresponding high resolution, 3dimensional reconstructed histopathology image data in an integrated, streamlined solution. This will lead to the optimization of the phenotypic and genotypic characterization of biopsied samples, reducing costs and delays in data analysis process.
“ Biological problems and solutions are inherently multiscale, and we’re excited to be working with SII to combine genotypic and phenotypic data to help cure disease.” stated Todd Huffman, CEO of 3Scan, Inc.
About Systems Imagination, Inc.
Systems Imagination (SII) is a privately held big data analytics company that offers Ultra High Definition Translational Medicine services and Bioinformatics On Demand™ to accelerate the discovery and evolution of scientific knowledge. SII’s Big Data to Knowledge (BD2K) Solution uses a proprietary knowledge computing platform and expert analytical services by a worldclass team of scientific and clinical experts, enabling clients to translate Big Data into useful scientific knowledge with unprecedented speed and precision Systems Imagination (SII) is a privately held big data analytics company that offers tech-enabled services and Bioinformatics On Demand™ to accelerate the discovery and evolution of scientific knowledge. SII’s Big Data to Knowledge (BD2K) Solution uses a proprietary knowledge computing platform and expert analytical services by a world-class team of scientific and clinical experts, enabling clients to translate Big Data into useful scientific knowledge with unprecedented speed and precision.
For more information, visit www.systemsimagination.com
About 3Scan, Inc.
3Scan is a privately held computational pathology platform that offers end-to-end services for histology, imaging, and analytical image analysis. 3Scan has engineered a novel imaging modality, the KnifeEdge Scanning Microscope (KESM), in order to fill the hole between radiology and pathology through automated imaging of large tissue volumes at single micron resolution. The output is quantitative, 3D, and comprehensive at a scale that would be unimaginable using current histological workflows. 3Scan offers novel insights into heterogeneous diseases by delivering systems level results at next generation speeds.
Find out more about 3Scan, Inc. at www.3scan.com
For more information, contact:
Chris Yoo
Chief Executive Officer
Systems Imagination, Inc.
480-422-1237
chris@siiventures.com